Asymmetric access to novel N‐protected (di)peptidyl β3‐aldehydes (“β3‐PAs”) has been achieved through direct coupling of a chiral non‐racemic 6‐alkoxytetrahydrooxazinone with N‐phthalyl L‐α‐amino acids. Kinetic resolution allows for the fruitful use of racemic amino acids in this process. Acidic hydrolysis of the diastereomerically pure, coupling products leads to the title N‐phthalyl‐β3‐PAs in high yields. (© Wiley‐VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2006)
No takes yet. Share an insight, caveat, or question.
Yin et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: